Data for: Advanced fibrosis of non-alcoholic steatohepatitis affects the significance of lipoprotein(a) as a cardiovascular risk factor

Published: 21 March 2020| Version 1 | DOI: 10.17632/62tfnxs232.1
Teruki Miyake


Lipoprotein(a) [Lp(a)] is an important independent cardiovascular risk factor. However, Lp(a) levels are lower in patients with chronic liver disease than in healthy subjects. Furthermore, Lp(a) levels decrease as residual liver function declines. Although non-alcoholic fatty liver disease (NAFLD), especially advanced non-alcoholic steatohepatitis (NASH), increases the risk of cardiovascular diseases, the relationship between serum Lp(a) level and NASH is unknown. Thus, we examined the relationship between serum Lp(a) levels and NAFLD and clarified the significance of Lp(a) measurements for cardiovascular disease screening in patients with NAFLD.



Lipoprotein, Non-Alcoholic Fatty Liver Disease, Cardiovascular Risk Factor